#

Vazhnoe

: 691
Latigo was created by venture capital firm Westlake BioPartners and staffed with former neuroscience employees from Amgen / Photo: THICHA SATAPITANON / Shutterstock
Small Caps·
+1
·
Latigo IPO: Non-opioid painkiller maker debuts on the Nasdaq
The company listed on NASDAQ under the ticker symbol BLSM. Photo: BlossomHill
News·
BlossomHill Therapeutics IPO: Cancer Drug Developer Goes Public
Electricity providers are benefiting from growing demand from data centers and the industrial sector. Photo: entergy.com
Review·
Where to Invest $10,000: Betting on Chip-Free AI and Protecting Against Volatility. August Ideas
SpaceX investors continue to pay for a compelling narrative rather than proven growth in the business, cautions the CFRA analyst / Photo: Frederic Legrand - COMEO / Shutterstock.com
News·
'A game of hot potato': An early SpaceX pessimist speaks with Oninvest on key risks
Photo: Seacalm/Shutterstock
News·
Braveheart Bio IPO: Shares in the cardiovascular drug developer are now available
Attovia is developing drugs using a licensed technology platform and patents, with one drug having completed dosing in a phase I trial and another expected to start trials in early 2027 / Photo: Unsplash / Mathurin Napoli / matnapo
Small Caps·
+1
·
Attovia IPO: Goldman-backed biotech debuts on the Nasdaq
The end of the first lock-up period for SpaceX investors could prove to be even more significant in terms of its impact on the stock price than the company’s first financial report. Photo: SpaceX / Unsplash.com
Review·
SpaceX at $100? In the coming days, the market will put Musk's strategy to the test
Elon Musks SpaceX will release its first quarterly report this week following its IPO / Photo: X/SpaceX
News·
SpaceX's Earnings Report, the Job Market, and Big Pharma: What Investors Can Expect This Week
Apnimed raised $192 million in an upsized U.S. IPO, priced at the top of a marketed range / Photo: LinkedIn / Apnimed
Small Caps·
+1
·
Apnimed IPO: Sleep apnea drug developer debuts on the Nasdaq
Leopold Aschenbrenner is the founder of the hedge fund Situational Awareness. Photo: X/leopoldasch
News·
Lessons for Wall Street: 6 Questions About Aschenbrenner, the “AI Nostradamus,” and the Collapse of His Fund
Jennifer Aniston in a $278 dress by Reformation / Photo: Getty Images/Steve Granitz/FilmMagic
News·
IPO Reformation: The Brand That Dressed Taylor Swift and Jennifer Aniston Goes Public
The history of the Jersey Mike’s brand began in 1956 / Photo: X/Jersey Mikes
News·
Jersey Mike’s IPO: Shares of the sandwich bar chain challenging Subway are now available
Load more